FDA issues alert about ‘possible accuracy concerns’ with rapid coronavirus test used by White House

Published



The Food and Drug Administration issued an alert about “possible accuracy problems” with the rapid coronavirus test used by the White House after studies questioned its accuracy.

A recent New York University study, which has not yet been peer-reviewed, found that Abbott’s ID NOW missed at least one-third of positive cases detected by a different test. The number of false negatives increased when using the currently recommended dry nasal swabs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.